# Thromboprophylaxis After Surgery for Gynecologic Malignancy in China

> **NCT02935530** · PHASE3 · COMPLETED · sponsor: **Huazhong University of Science and Technology** · enrollment: 315 (actual)

## Conditions studied

- Gynecologic Neoplasms
- Venous Thromboembolism
- Low Molecular Weight Heparin
- Argatroban

## Interventions

- **DRUG:** s-LMWH
- **DRUG:** LMWH
- **DRUG:** Argatroban

## Key facts

- **NCT ID:** NCT02935530
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2017-08
- **Final completion:** 2017-10
- **Target enrollment:** 315 (ACTUAL)
- **Last updated:** 2019-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02935530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02935530, "Thromboprophylaxis After Surgery for Gynecologic Malignancy in China". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02935530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*